United Therapeutics Corporation
TREPROSTINIL DERIVATIVES AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS
Last updated:
Abstract:
Provided are treprostinil derivatives with a reduced ability to form undesired impurities in a pharmaceutical formulation, such as a dry powder formulation, further containing a carboxyl group containing inactive ingredient, such as fumaryl diketopiperazine.
Status:
Application
Type:
Utility
Filling date:
2 Mar 2022
Issue date:
8 Sep 2022